Recruiting Multiple Sclerosis Studies in Middletown
A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
The purpose of this study is to find out whether selinexor is an effective treatment for people who have a relapsed/refractory Wilms tumor, rhabdoid tumor, MPNST, or another solid tumor that makes a h...
Ulixertinib in People With Histiocytic Neoplasms
The researchers are doing this study is to find out whether ulixertinib is an effective and safe treatment for people with histiocytic neoplasms....
About Multiple Sclerosis Clinical Trials in Middletown
Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.
There are currently 2 multiple sclerosis clinical trials recruiting participants in Middletown, NEW%20YORK. These studies are seeking a combined 83 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.
Multiple Sclerosis Clinical Trials in Middletown — FAQ
Are there multiple sclerosis clinical trials in Middletown?
Yes, there are 2 multiple sclerosis clinical trials currently recruiting in Middletown, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Middletown?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Middletown research site will contact you about next steps.
Are clinical trials in Middletown free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Middletown studies also compensate for your time and travel.
What multiple sclerosis treatments are being tested?
The 2 active trials in Middletown are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.
Data updated March 2, 2026 from ClinicalTrials.gov